FTSE All-Share

FTSE All-Share handeln
5.509,65 PKT -11,30 PKT -0,20 %
finanzen.net zero
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Smartphone

WKN 621441

ISIN GB0031758641


Analysen zu FTSE All-Share-Werten

Datum Rating Analyst
30.01.24 AstraZeneca Overweight JP Morgan Chase & Co.
30.01.24 Diageo Neutral JP Morgan Chase & Co.
29.01.24 Shell (ex Royal Dutch Shell) Outperform RBC Capital Markets
29.01.24 BAT Neutral UBS AG
26.01.24 BP Outperform RBC Capital Markets
26.01.24 BP Buy UBS AG
26.01.24 Glencore Buy UBS AG
24.01.24 Diageo Hold Jefferies & Company Inc.
23.01.24 Unilever Sell UBS AG
23.01.24 BAT Neutral UBS AG
23.01.24 Rio Tinto Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
23.01.24 Rio Tinto Sector Perform RBC Capital Markets
23.01.24 Glencore Outperform RBC Capital Markets
22.01.24 Unilever Sell UBS AG
19.01.24 Unilever Sell UBS AG
19.01.24 Rio Tinto Overweight JP Morgan Chase & Co.
19.01.24 Unilever Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.01.24 Vodafone Group Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
18.01.24 AstraZeneca Hold Deutsche Bank AG
17.01.24 BP Underweight JP Morgan Chase & Co.
17.01.24 BP Buy UBS AG
17.01.24 Rio Tinto Buy Deutsche Bank AG
17.01.24 Diageo Sell Deutsche Bank AG
17.01.24 Glencore Hold Deutsche Bank AG
17.01.24 BP Outperform RBC Capital Markets
17.01.24 BP Hold Jefferies & Company Inc.
17.01.24 Vodafone Group Neutral JP Morgan Chase & Co.
16.01.24 BP Buy UBS AG
16.01.24 Shell (ex Royal Dutch Shell) Neutral UBS AG
16.01.24 Rio Tinto Overweight JP Morgan Chase & Co.
16.01.24 Rio Tinto Sector Perform RBC Capital Markets
16.01.24 Rio Tinto Overweight Barclays Capital
16.01.24 HSBC Neutral JP Morgan Chase & Co.
16.01.24 Shell (ex Royal Dutch Shell) Overweight JP Morgan Chase & Co.
16.01.24 BP Underweight JP Morgan Chase & Co.
16.01.24 AstraZeneca Hold Jefferies & Company Inc.
16.01.24 GSK Buy Jefferies & Company Inc.
16.01.24 Rio Tinto Neutral UBS AG
16.01.24 AstraZeneca Sell UBS AG
15.01.24 GSK Buy UBS AG